May 20th, 2006

Unease on Industry's Role in Hypertension Debate

By Stephanie Saul
The New York Times

Three pharmaceutical companies donated $700,000 to a medical society that used most of the money on a series of dinner lectures last year to brief doctors on the latest news about high blood pressure. The same three companies Merck, Novartis and Sankyo also gave the money that the medical society used to formulate the main talking point of those briefings, an expanded concept of high blood pressure that many doctors say would increase the number of people taking drugs.

Read the full article here.

Comments

Add your own Comment

(optional)